Decision Analysis of the COVID-19 Vaccines

Decision Analysis of the COVID-19 Vaccines

The entire globe is struggling with the COVID-19 pandemic since March 11, 2020. There is still a large number of infected patients and death, and there is no proven treatment for the infection yet. This has led to the race in vaccine development to protect people from COVID-19 infection. As of Febru...

Full description

Bibliographic Details
Main Authors: Ozsahin Dilber Uzun, Gelisen Mehmet Ilker, Taiwo Mustapha, Agachan Yasemin, Rahi Dorrin, Uzun Berna
Format: Article
Language:English
Published: Sciendo 2021-06-01
Series:The EuroBiotech Journal
Subjects:
covid-19
mcdm
pamdemic
promethee
vaccine
Online Access:https://doi.org/10.2478/ebtj-2021-0017
id doaj-0dd66ce2ae604239afa9cba7d0928252
record_format Article
spelling doaj-0dd66ce2ae604239afa9cba7d09282522021-09-05T21:00:45ZengSciendoThe EuroBiotech Journal2564-615X2021-06-015s1202510.2478/ebtj-2021-0017Decision Analysis of the COVID-19 VaccinesOzsahin Dilber Uzun0Gelisen Mehmet Ilker1Taiwo Mustapha2Agachan Yasemin3Rahi Dorrin4Uzun Berna5DESAM Institute, Near East University, Nicosia, TRNC, Mersin 10, TurkeyCommon Course Coordination, Near East University, Nicosia, TRNC, Mersin 10, TurkeyDESAM Institute, Near East University, Nicosia, TRNC, Mersin 10, TurkeyFaculty of Pharmacy, Near East University, Nicosia, TRNC, Mersin 10, TurkeyFaculty of Dentistry, Near East University, Nicosia, TRNC, Mersin 10, TurkeyDESAM Institute, Near East University, Nicosia, TRNC, Mersin 10, TurkeyThe entire globe is struggling with the COVID-19 pandemic since March 11, 2020. There is still a large number of infected patients and death, and there is no proven treatment for the infection yet. This has led to the race in vaccine development to protect people from COVID-19 infection. As of February 3, 2021, there were 289 experimental COVID -19 vaccines in development, 66 of which were in clinical trials with different phases, and 20 of them were in phase 3.https://doi.org/10.2478/ebtj-2021-0017covid-19mcdmpamdemicprometheevaccine
collection DOAJ
language English
format Article
sources DOAJ
author Ozsahin Dilber Uzun
Gelisen Mehmet Ilker
Taiwo Mustapha
Agachan Yasemin
Rahi Dorrin
Uzun Berna
spellingShingle Ozsahin Dilber Uzun
Gelisen Mehmet Ilker
Taiwo Mustapha
Agachan Yasemin
Rahi Dorrin
Uzun Berna
Decision Analysis of the COVID-19 Vaccines
The EuroBiotech Journal
covid-19
mcdm
pamdemic
promethee
vaccine
author_facet Ozsahin Dilber Uzun
Gelisen Mehmet Ilker
Taiwo Mustapha
Agachan Yasemin
Rahi Dorrin
Uzun Berna
author_sort Ozsahin Dilber Uzun
title Decision Analysis of the COVID-19 Vaccines
title_short Decision Analysis of the COVID-19 Vaccines
title_full Decision Analysis of the COVID-19 Vaccines
title_fullStr Decision Analysis of the COVID-19 Vaccines
title_full_unstemmed Decision Analysis of the COVID-19 Vaccines
title_sort decision analysis of the covid-19 vaccines
publisher Sciendo
series The EuroBiotech Journal
issn 2564-615X
publishDate 2021-06-01
description The entire globe is struggling with the COVID-19 pandemic since March 11, 2020. There is still a large number of infected patients and death, and there is no proven treatment for the infection yet. This has led to the race in vaccine development to protect people from COVID-19 infection. As of February 3, 2021, there were 289 experimental COVID -19 vaccines in development, 66 of which were in clinical trials with different phases, and 20 of them were in phase 3.
topic covid-19
mcdm
pamdemic
promethee
vaccine
url https://doi.org/10.2478/ebtj-2021-0017
work_keys_str_mv AT ozsahindilberuzun decisionanalysisofthecovid19vaccines
AT gelisenmehmetilker decisionanalysisofthecovid19vaccines
AT taiwomustapha decisionanalysisofthecovid19vaccines
AT agachanyasemin decisionanalysisofthecovid19vaccines
AT rahidorrin decisionanalysisofthecovid19vaccines
AT uzunberna decisionanalysisofthecovid19vaccines
_version_ 1717782347915460608

Similar Items